(Washington, D.C.) — As drugstore lobbyists descend on Albany today, it is important to highlight how pharmacy benefit managers (PBMs) advocate for consumers and health plan sponsors in the fight to keep prescription drugs accessible and affordable. It is equally
PCMA Business Forum 2025 The PCMA Business Forum 2025 is heading back to the Signia by Hilton Orlando, Bonnet Creek in Orlando, FL, March 10 & 11. Don’t miss the industry’s most important business development, networking and educational conference. The
Mark Merritt, chief executive of PCMA, dislikes the proposal and believes the Medicare coverage is a “sound program”
JC Scott speaks with Doug Long, Vice President of Industry Relations at IQVIA, about the impact of COVID-19 on the pharmaceutical market. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare
Greg Lopes, a spokesman for the Pharmaceutical Care Management Association, said PBMs believe the key to lowering costs for insulin, and drugs more broadly, is more competition among manufacturers. He said drug companies have avoided doing that through tactics like extending patents on insulin products.
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing the additions of Jack Linehan as General Counsel, Agnita Kote as Chief Financial Officer, Zach Pleasant as Director, Technology and Operations, and the promotion of Amanda Frost to Vice
This week, the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee considers legislation that would lower choice in the market by creating a one-size-fits all pharmacy benefit contracting model for health plans and employers. As Congress considers mandating contracting
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the New York Senate Investigations and Government Operations Committee’s report on pharmacy benefit managers (PBMs). “This report attempts to undermine the only industry that is reducing prescription drug
(Washington, D.C.) – As independent drugstore lobbyists descend on Albany for their special interest lobby day, the Pharmaceutical Care Management Association (PCMA) released the following statement: “Pharmacy benefit managers (PBMs) advocate on behalf of New York’s consumers and health plan sponsors by negotiating
The Value of Pharmacy Benefit Management PBMs Create $145 Billion in Value Annually Groundbreaking research by University of Chicago Economics Professor Casey Mulligan describes the services that pharmacy benefit managers (PBMs) provide in the healthcare marketplace to patients, health plans,
©2024 PCMA. All Rights Reserved.
